Palo Alto Investors »

Madrigal Pharmaceuticals shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2026-03-31 $935k 1.8k 523.47

More positions owned by Palo Alto Investors

Insmed Com Par $.01 (INSM)
ACADIA Pharmaceuticals (ACAD)
Ptc Therapeutics I (PTCT)
BioMarin Pharmaceutical (BMRN)
United Therapeutics Corporation (UTHR)
Anaptysbio Inc Common (ANAB)
Mirum Pharmaceuticals (MIRM)
Dyne Therapeutics (DYN)
Biogen Idec (BIIB)
Disc Medicine (IRON)
Iovance Biotherapeutics (IOVA)
Syndax Pharmaceuticals (SNDX)
Annexon (ANNX)
Amicus Therapeutics (FOLD)
Novocure Ord Shs (NVCR)

View all positions for Palo Alto Investors

Top funds holding Madrigal Pharmaceuticals

Baker Bros. Advisors
Henderson Group
Rtw Investments
venBio Select Advisor
Vanguard Group
BlackRock
Paulson & Co
Vanguard Portfolio Management
Vanguard Capital Management
Wellington Management Company
State Street Corporation
Citadel Advisors
FMR
Geode Capital Management
William Blair Investment Management

View all funds holding Madrigal Pharmaceuticals